Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00052598
Status:
TERMINATED
Last Update Posted:
2017-02-15
First Post:
2003-01-24
Brief Title:
Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Acute Myeloid Leukemia |
| Accelerated Phase Chronic Myelogenous Leukemia |
| Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Blastic Phase Chronic Myelogenous Leukemia |
| Childhood Chronic Myelogenous Leukemia |
| Childhood Myelodysplastic Syndromes |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Relapsing Chronic Myelogenous Leukemia |
Keywords: